Anti-Bacterial Agents - Immunology
Research News and Information

Sunday, November 22, 2009

Vitellogenin is a cidal factor capable of killing bacteria via interaction with lipopolysaccharide and lipoteichoic acid.

31 Aug 2009 Vitellogenin (Vg) has been shown to be involved in host immune defense. However, the underlying mechanism by which Vg functions is largely unknown, and which component in Vg is essential for the execution of its immune role remains lacking. Here, we ... Read more...

Mouse eosinophils possess potent antibacterial properties in vivo.

22 Aug 2009 Eosinophils are best known as the predominant cellular infiltrate associated with asthma and parasitic infections. Recently, numerous studies have documented the presence of Toll-like receptors (TLRs) on the surfaces of eosinophils, suggesting that ... Read more...

Alpha-defensins in enteric innate immunity: functional Paneth cell alpha-defensins in mouse colonic lumen.

15 Aug 2009 Paneth cells are a secretory epithelial lineage that release dense core granules rich in host defense peptides and proteins from the base of small intestinal crypts. Enteric alpha-defensins, termed cryptdins (Crps) in mice, are highly abundant in ... Read more...

Latest indexed articles for 'Anti-Bacterial Agents - Immunology'

These are the very latest articles for this heading:

• Vitellogenin is a cidal factor capable of killing bacteria via interaction with lipopolysaccharide and lipoteichoic acid. 31 Aug 2009
• Mouse eosinophils possess potent antibacterial properties in vivo. 22 Aug 2009
• Alpha-defensins in enteric innate immunity: functional Paneth cell alpha-defensins in mouse colonic lumen. 15 Aug 2009
• Skin testing in delayed reactions to drugs. 30 Jul 2009
• The bactericidal effect of a complement-independent antibody is osmolytic and specific to Borrelia. 17 Jun 2009
• Sequence and specificity of two antibacterial proteins involved in insect immunity. Nature 292: 246-248. 1981. 30 May 2009
• Porins facilitate nitric oxide-mediated killing of mycobacteria. 17 May 2009
• Pharmacokinetics and safety profile of the human anti-Pseudomonas aeruginosa serotype O11 immunoglobulin M monoclonal antibody KBPA-101 in healthy volunteers. 16 May 2009
• [Assessment of safety of lyophilized substance of antibacterial peptide complex] 29 Apr 2009
• Contact dermatitis in leg ulcer patients. 29 Apr 2009
• Management of tolerance induction in patients with suspected penicillin allergy--a case study. 29 Apr 2009
• Monoclonal antibody production and immunochemical detection of polyether antibiotics. 21 Apr 2009
• Cefaclor anaphylaxis in children. 4 Apr 2009
• Isolation and characterization of a hepcidin peptide from the head kidney of large yellow croaker, Pseudosciaena crocea. 30 Mar 2009
• Multiple drug hypersensivity: insight into the underlying mechanism and correlation with autoimmune diseases. 30 Mar 2009
• Dermal cytolytic peptides and the system of innate immunity in anurans. 30 Mar 2009
• Development of an enrofloxacin immunosensor based on label-free electrochemical impedance spectroscopy. 12 Mar 2009
• Severe allergic reaction to hydrochlorothiazide mimicking septic shock. 27 Feb 2009
• Immune hemolysis due to piperacillin/tazobactam. 25 Feb 2009
• Allergy diagnostic testing in clindamycin-induced skin reactions. 10 Feb 2009

See a longer list of these articles.

Technical information about 'Anti-Bacterial Agents'

Definition: Substances that reduce the growth or reproduction of BACTERIA.

Registry Number: 0

Descriptor UI: D000900

Alternative terms: Anti-Bacterial Agents; Agents, Anti-Bacterial; Anti Bacterial Agents; Antibacterial Agents; Agents, Antibacterial; Antibiotics; Bacteriocidal Agents; Agents, Bacteriocidal; Bacteriocides; Anti-Mycobacterial Agents; Agents, Anti-Mycobacterial; Anti Mycobacterial Agents; Antimycobacterial Agents; Agents, Antimycobacterial;

Allowable Qualifiers: administration & dosage; adverse effects; analysis; antagonists & inhibitors; biosynthesis; blood; cerebrospinal fluid; chemical synthesis; classification; diagnostic use; economics; history; immunology; isolation & purification; metabolism; pharmacokinetics; pharmacology; poisoning; radiation effects; standards; supply & distribution; therapeutic use; toxicity; urine; chemistry; contraindications; agonists;

Tree Number: D27.505.954.122.085;

History Note: 2004(1963)

Technical Notes: GEN or unspecified; resistance to antibiotics = DRUG RESISTANCE, BACTERIAL or specifics; preop use of antibiotics for prev of infect: index under ANTIBIOTIC PROPHYLAXIS (IM) + specific antibiotic /ther use (IM)